Panbela Therapeutics Inc (PBLA)
0.48
+0.08
(+20.00%)
USD |
OTCM |
May 16, 16:00
Panbela Therapeutics Cash from Operations (Quarterly): -3.08M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.08M |
| September 30, 2023 | -6.677M |
| June 30, 2023 | -5.741M |
| March 31, 2023 | -9.751M |
| December 31, 2022 | -5.003M |
| September 30, 2022 | -1.593M |
| June 30, 2022 | -4.197M |
| March 31, 2022 | -4.483M |
| December 31, 2021 | -2.228M |
| September 30, 2021 | -1.359M |
| June 30, 2021 | -1.693M |
| March 31, 2021 | -1.965M |
| December 31, 2020 | -1.113M |
| September 30, 2020 | -0.765M |
| June 30, 2020 | -0.856M |
| March 31, 2020 | -1.12M |
| December 31, 2019 | -0.872M |
| September 30, 2019 | -0.453M |
| June 30, 2019 | -0.631M |
| March 31, 2019 | -0.783M |
| December 31, 2018 | -0.162M |
| September 30, 2018 | -0.64M |
| June 30, 2018 | -0.997M |
| March 31, 2018 | -0.588M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.783M |
| September 30, 2017 | -0.261M |
| June 30, 2017 | -1.286M |
| March 31, 2017 | -1.072M |
| December 31, 2016 | -0.828M |
| September 30, 2016 | -0.939M |
| June 30, 2016 | -0.089M |
| March 31, 2016 | -0.542M |
| December 31, 2015 | -0.878M |
| September 30, 2015 | -0.878M |
| June 30, 2015 | -1.234M |
| March 31, 2015 | -0.907M |
| December 31, 2014 | -1.169M |
| September 30, 2014 | -2.207M |
| June 30, 2014 | 0.0163M |
| March 31, 2014 | 0.0164M |
| December 31, 2013 | 0.1025M |
| September 30, 2013 | -0.003M |
| June 30, 2013 | -0.0473M |
| March 31, 2013 | -0.0875M |
| December 31, 2012 | -0.0338M |
| September 30, 2012 | -0.0089M |
| June 30, 2012 | 0.1076M |
| March 31, 2012 | -0.0278M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.751M
Minimum
Mar 2023
-0.453M
Maximum
Sep 2019
-2.82M
Average
-1.693M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 4.749M |
| Free Cash Flow | -25.25M |
| Free Cash Flow Per Share (Quarterly) | -6.416 |
| Free Cash Flow Yield | -31.15K% |